Literature DB >> 12610545

Fibrillin controls TGF-beta activation.

Vesa Kaartinen, David Warburton.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12610545     DOI: 10.1038/ng0303-331

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  58 in total

Review 1.  Lung organogenesis.

Authors:  David Warburton; Ahmed El-Hashash; Gianni Carraro; Caterina Tiozzo; Frederic Sala; Orquidea Rogers; Stijn De Langhe; Paul J Kemp; Daniela Riccardi; John Torday; Saverio Bellusci; Wei Shi; Sharon R Lubkin; Edwin Jesudason
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

2.  Exon 47 skipping of fibrillin-1 leads preferentially to cardiovascular defects in patients with thoracic aortic aneurysms and dissections.

Authors:  Wen-Jing Wang; Peili Han; Jun Zheng; Fang-Yuan Hu; Yun Zhu; Jin-Sheng Xie; Jian Guo; Zhe Zhang; Jie Dong; Gu-Yan Zheng; Huiqing Cao; Tian-Shu Liu; Qinglin Fu; Lizhong Sun; Bi-Bo Yang; Xiao-Li Tian
Journal:  J Mol Med (Berl)       Date:  2012-07-08       Impact factor: 4.599

3.  Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling.

Authors:  Clarissa S Craft; Wei Zou; Marcus Watkins; Susan Grimston; Michael D Brodt; Thomas J Broekelmann; Justin S Weinbaum; Steven L Teitelbaum; Richard A Pierce; Roberto Civitelli; Matthew J Silva; Robert P Mecham
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

4.  When the lung is stretched, could it be thrombospondin via TGFbeta1 peptide activation?

Authors:  David Warburton; Vesa Kaartinen
Journal:  J Physiol       Date:  2007-10-11       Impact factor: 5.182

5.  The new biology: a bridge to clinical cardiology.

Authors:  Ge Louridas; Kg Lourida
Journal:  Hippokratia       Date:  2012-04       Impact factor: 0.471

Review 6.  Growth Factors, Oxidative Damage, and Inflammation in Exfoliation Syndrome.

Authors:  Teresa Borrás
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

7.  Marfan syndrome and mitral valve prolapse.

Authors:  Arthur E Weyman; Marielle Scherrer-Crosbie
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 8.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

9.  Determination of the molecular basis of Marfan syndrome: a growth industry.

Authors:  Peter H Byers
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Angiotensin II Receptor Antagonism Reduces Transforming Growth Factor Beta and Smad Signaling in Thoracic Aortic Aneurysm.

Authors:  Maria Nataatmadja; Jennifer West; Sulistiana Prabowo; Malcolm West
Journal:  Ochsner J       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.